Objective: The present study aimed to determine the role of excitatory amino acids (EAAs) and EAA transporters (EAATs) in an osteoarthritis (OA) model of rabbit knees.
Introduction
Osteoarthritis (OA) is the most prevalent form of arthritis in the United States and is often associated with significant disability and impaired quality of life 1 . OA is a synovial joint disorder that is characterized by the destruction of the articular cartilage accompanied by inflammation 2, 3 . Patients with rupture of the anterior cruciate ligament (ACL) develop post-traumatic OA of the knee degenerative changes in the ACL-injured knee 5 . This suggests that the development of post-traumatic OA not only has a biomechanical origin but may also involve biochemical changes.
Glutamate is a well-known excitatory neurotransmitter in the mammalian central nervous system (CNS), being responsible for up to one-third of the excitatory synaptic functions 6 . Growing evidence indicates that glutamate also plays a role in cell signaling in peripheral tissues such as the bone 7e9 . Glutamate increases in the innervated axons of inflamed knee joints 10 and the synovial fluid of arthritic patients 11 . The injection of a kaolin/carrageenan mixture into the knee joint induces an immediate increase in the glutamate and aspartate levels in the joint; this increase persists for hours 12 . We previously reported that glutamate and aspartate levels are significantly increased in the dialysates of ACLT rat knees and suggested that excitatory amino acids (EAAs) play a role in early OA development 13 . The physiological extracellular concentration of glutamate is regulated by the action of high-affinity, sodium-dependent EAA transporters (EAATs) 6 . EAATs are the key mechanism for the clearance and maintenance of extracellular glutamate concentrations at excitatory synapses and thus for the termination of glutamate signaling. At least five EAATs have been identified 6, 14 . Glutamate/aspartate transporter (GLAST, EAAT1), glutamate transporter-1 (GLT-1, EAAT2), EAA carrier 1 (EAAC1, EAAT3), EAAT 4 (EAAT4), and EAAT5.
Mason et al. first demonstrated glutamate signaling and downregulation of GLAST mRNA by mechanical loading in rat bone 15 . Mechanical regulation of neural EAATs expression has recently been described in bones, suggesting that EAAs play a role in paracrine intercellular communication 15 . Over the last few years, a small but growing number of researchers have provided increasing evidence to support the role of glutamate as an important mediator of bone cell functions 7, 8 . Thus far, however, little attention has been paid to EAAT expression in the knee joint and its role in OA development. The present study, using the ACLT rabbit model, examined the concentration change in EAAs during OA development and the concomitant expression of GLAST, GLT-1, and EAAC1 in the articular cartilage of the knee joints.
Methods

ANIMAL MODEL
The use of animals conformed to the Guiding Principles in the Care and Use of Animals of the American Physiology Society and was approved by the Animal Care and Use Committee of the National Sun Yat-Sen University, Taiwan. A total of 25 healthy New Zealand white adult male rabbits (body weight: 1530e1620 g) were used in this study. OA was induced in New Zealand white male rabbits via ACL transection (ACLT) in one knee of one hind limb; the other knee was left unoperated. Rabbits that received ACLT were assigned to the ACLT group (n ¼ 6), while the sham-operated group (n ¼ 6) underwent arthrotomy with no ACLT. Six na€ ıve rabbits that received no surgery were used as normal control. For the sham operation, the ACL of the knee was exposed but not transected. This procedure was modified from the protocol described by Stoop et al. 16 . Rabbits were allowed daily unrestricted cage activity after surgery. Wound healing and infection or any other complications were monitored continuously during the 30-week observation period.
CONSTRUCTION AND PLACEMENT OF THE MICRODIALYSIS PROBE
A microdialysis probe was implanted in each rabbit knee joint under isoflurane anesthesia for joint dialysate collection before (baseline) and at 5, 10, 20, and 30 weeks after the ACLT or sham operation. The construction and placement of the microdialysis probe were done according to our previous reports 13, 17 . For the in vitro measurement, the average recovery rate of the dialysis probe was 19.5 AE 5.2% at an infusion rate of 1.5 mL/min of eight different microdialysis probes. All samples were collected in polypropylene tubes, kept on ice, and then frozen at À80 C until assayed.
MEASUREMENT OF EAAs
High-performance liquid chromatography (HPLC) with a fluorescence detector (pump 126, Beckman Instruments Inc., Fullerton, CA, USA) was used. The protocol for EAA detection was according to our previously described methods 18 . External standards containing 0, 10 À8 , 10 À7 , 10 À6 , or 10 À5 M standard amino acids were run before and after each sample group. The detection sensitivity was 10 À8 M. All standards and samples were analyzed in duplicate.
INFLAMMATION, GROSS MORPHOLOGY, AND HISTOPATHOLOGICAL EXAMINATIONS OF KNEE JOINTS
The severity of knee joint inflammation was reflected by an increase in the hind limb knee joint width. The width of the bilateral hind limb knee joints was measured from the medial to the lateral aspect of the joint line by using calipers before (baseline) and at 5, 10, 15, 20, 25, and 30 weeks after operation. At week 30 after surgery and microdialysis sample collection, the rabbits were sacrificed, and the rabbit knees were disarticulated immediately after death. Gross morphologic changes in the cartilage of the medial femoral condyle were examined according to previously described methods 19, 20 . The joints were cut 0.5 cm above and below the joint line, fixed in 10% neutral buffered formalin for 3 days, and then decalcified for 2 weeks in buffered 12.5% ethylene diamine tetraacetic acid (EDTA)/formalin solution. The joints were cut in the mid-saggital plane, washed in running tap water, and paraffin-embedded in an automatic processor (Autotechnicon mono 2, Technion Co., Chauncey, NY, USA). Serial articular cartilage sections (2 mm) were cut using a microtome (Microm HM340E, Walldorf, Germany) from the central weight-bearing surface of the medial femoral condyles of the ACLT, sham-operated, and na€ ıve knees. Cartilage was stained with hematoxylin/eosin (H/E) and safranin-O/fast green stains to assess general morphology and matrix proteoglycans. Microscopic examination of the articular cartilage in the medial femoral condyles was graded according to the Mankin's grading system 21 . A representative specimen of the synovial membrane from the medial and lateral compartments of the knee was dissected from the underlying tissues for histological examination, as previously described 22 .
IMMUNOHISTOCHEMISTRY FOR EAATs
Cartilage specimens were processed for immunohistochemistry, as described previous 23 . Sections (2 mm) of paraffin-embedded specimens were placed on slides, deparaffinized with xylene, dehydrated in graded series of ethanol, and the endogenous peroxidase activity was quenched by 30 min of incubation in 0.3% H 2 O 2 in methanol at room temperature. The antigen was retrieved by enzymatic digestion with proteinase K (Sigma; 20 mM) in phosphate buffered saline (PBS) for 20 min at room temperature in a humid chamber. The slides were incubated with the primary antibody against either GLAST (1:100 dilution; Chemicon) or GLT-1 (1:50 dilution; BD Biosciences Pharmingen) in 0.3% Triton X-100 in PBS overnight at 4 C in a humidified chamber. Thereafter, sections were treated with avidinebiotin complex (ABC) technique using the ABC kit (Vectastain ABC kit; Vector, Burlingame, CA, USA). Sections from the negative control samples were incubated with PBS without antibody. The images were viewed using a Leica DM-1000 microscope (Leica, Heidelberg, Germany) and captured using a SPOT CCD RT-slider integrating camera (Diagnostic Instruments Inc., USA).
WESTERN BLOT ANALYSIS FOR EAATs
Rabbits were anesthetized with isoflurane, and full-thickness pieces of the articular cartilages of the tibial plateau and femoral condyle were removed aseptically from the subchondral bone with a scalpel, washed with iced PBS, and cut into small pieces with scissors. The cartilage was homogenized in ice-cold lysis buffer (50 mM Tris at pH 7.5, 150 mM NaCl, 2% Triton X-100, 100 g/mL phenylmethylsulfonyl fluoride, and 1 mg/mL aprotinin) by using a rotor/stator homogenizer (2000 rpm, three times for 10 s each). All samples were then sonicated three times using a Microson ultrasonic cell disruptor (Heat Systems, Farmingdale, NY, USA) for 15 s each at 20% output power. The homogenates were centrifuged at 50,000g (TXL-100, Beckman, USA) for 30 min at 4 C. For EAAT analysis, a 50 mg cartilage homogenate sample was obtained. In brief, an equal volume of sample buffer [2% sodium dodecyl sulfate (SDS), 10% glycerol, 0.1% bromophenol blue, 2% 2-mercaptoethanol, and 50 mM TriseHCl at pH 7.2] was added to the sample, which was then loaded onto a 10% SDSepolyacrylamide gel, and electrophoresis was performed at 150 V for 60 min. The proteins were transferred to a polyvinylidene difluoride membrane (0.45 M pore size, Immobilon-P; Millipore) at 125 mA overnight at 4 C in a transfer buffer (50 mM TriseHCl, 380 mM glycine, 1% SDS, and 20% methanol); thereafter, the membrane was blocked for 50 min at room temperature with 5% non-fat dry milk in 0.1% Tween-20 in 20 mM TriseHCl and 137 mM NaCl at pH 7.4 Tris Tween Buffer Saline (TTBS), and incubated for 180 min at room temperature with antibodies against GLAST (EAAT1, 1:1000 dilution; Chemicon, Temecula, CA, USA), GLT-1 (EAAT2, 1:1000 dilution; BD Biosciences Pharmingen), and EAAC1 (EAAT3, 1:1000 dilution; Chemicon, Temecula, CA, USA). Immunoblotting was then performed using appropriate antibodies and then with horseradish peroxidase (HRP)-conjugated secondary antibody (Jackson Immuno Research Laboratories Inc., USA). The immunoreactive bands were visualized by enhanced chemiluminescence (ECL kit; Millipore, Bedford, MA, USA), and then the images were visualized using the UVP BioChemi Imaging System. Relative densitometric quantification was then performed using LabWorks 4.0 software (UVP, Upland, CA, USA). The relative variations between the bands of the various treatment samples and the control group (right side of the na€ ıve knee) were calculated using the same image.
DATA AND STATISTICAL ANALYSIS
All data are presented as the mean AE standard deviation (SD) and were analyzed by one-way analysis of variance (ANOVA) according to the StudenteNewmaneKeuls post hoc test for multiple comparisons. For the immunoreactivity data, the intensity of each test band was expressed as the integrated optical density. A significant difference was defined as a P value of <0.05.
Results
KNEE JOINT WIDTH AND GROSS MORPHOLOGICAL CHANGES
The severity of knee inflammation, reflected by an increase in the width of the hind limb knee joint, was significant at 5, 10, 15, 20, 25, and 30 weeks after the surgery in the ACLT knee group. In the ACLT knees, the joint width was 5.3 AE 0.9 mm greater than the contralateral knee at 30 weeks after the operation, while the sham-operated knees and the na€ ıve knees exhibited no significant change in this regard ( Fig. 1 , P < 0.05). In the articular cartilage of the ACLT knees, an edematous change was observed, accompanied by mild focal fibrillation and pitting and thinning of the medial femoral condyle. Osteophytes were visible in all femoral condyles and tibial plateaus in the ACLT knee joints at 30 weeks after surgery. The macroscopic scores were 2.68 AE 0.78 in the ACLT group (Table I ). In the sham-operated and na€ ıve knees of the rabbits, the cartilage on the medial femoral condyles was normal, with a glistening translucent smooth surface, and no cartilage defects or osteophytes were observed; the macroscopic scores were 0.15 AE 0.04 and 0.12 AE 0.02, respectively (Table I) . Significant differences in the macroscopic scores were observed between the ACLT knees and both the sham-operated and na€ ıve knees (Table I ). The synovium exhibited congestion and inflammation in the ACLT knees, but no hyperemia or evidence of synovitis was observed in the sham-operated and na€ ıve knees.
MICROSCOPIC FINDINGS
Specimens obtained from the ACLT knees exhibited focal fibrillation extending through the superficial zone up to the superficial zoneemid zone region. Moreover, loss of safranin-O/fast green staining in the calcified cartilage layer and cleft, depletion of chondrocytes in the cartilage layer, hyperplasia of chondrocytes, and irregularity of the bony trabeculum at the junction between the calcified cartilage and subchondral layer were observed in the ACLT knees. In the sham-operated and na€ ıve knees, the histological appearance of the medial femoral condyles was normal; the cartilage surface was smooth with no superficial zone discontinuity. The matrix and associated chondrocytes were organized into three appropriately oriented, well-ordered zones. No enlargement, distortion, or proliferative changes were observed in the chondrocytes. Further, preservation of safranin-O/fast green staining, normal chondrocytes in the calcified cartilage layer, and smooth bony trabeculum in the subchondral layer were observed. Significant differences in the histological Mankin score for OA were observed between the ACLT knees (8.50 AE 0.93) and both the sham-operated (1.83 AE 0.62) and na€ ıve knees (1.20 AE 0.53) (P < 0.05) ( Table II) . The synovium of the ACLT knees was thick with focal villi and Data are expressed as mean AE SD. ACLT, rabbits that underwent ACLT of the knee; sham, rabbits that only underwent arthrotomy of the knee; na€ ıve, normal control rabbits that did not undergo any surgery. *P < 0.05 when compared with the sham-operated and na€ ıve groups. Data are expressed as mean AE SD. ACLT, rabbits that underwent ACLT of the knee; sham, rabbits that only underwent arthrotomy of the knee; na€ ıve, normal control rabbits that did not undergo any surgery. For details on the osteoarthritic score (Mankin score) and the synovitis score, refer to the Methods. *P < 0.05 when compared with the sham-operated and na€ ıve groups.
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exhibited hyperplasia of the lining cells, with moderate mononuclear cell infiltration. The histology of the synovium was normal in the sham-operated and na€ ıve knees. The synovitis scores are shown in Table II ; the score was significantly higher in the ACLT group (9.50 AE 1.47, P < 0.05) than in both the sham-operated (2.01 AE 0.64) and na€ ıve groups (1.83 AE 0.83) ( Table II) . Table III shows the concentration of aspartate and glutamate in the knee dialysates of baseline (before surgery) and at 10, 20, and 30 weeks after surgery in the knees of na€ ıve, sham, and ACLT groups. No significant difference was observed in the baseline level of EAAs among the three groups. For statistics analysis consider the aspartate and glutamate level in the contralateral knee as the 100% control. As shown in Fig. 2 , at week 30 after the ACLT surgery, the levels of aspartate and glutamate in the ACLT knee dialysates were 187.5 AE 33.8% and 213.3 AE 29.6%, respectively (considering the corresponding levels in the contralateral knee as 100%). A significant increase in the glutamate level was observed in the ACLT knees (213.3 AE 29.6%) (P < 0.05) when compared with that in the sham-operated knees [ Fig. 2(B) ]. In brief, from week 10 to week 30 after surgery, both the aspartate and glutamate levels were significantly increased in the joint dialysates of the ACLT knees when compared with these in the sham-operated knees (P < 0.05). No difference was observed in the aspartate and glutamate concentrations between the right and left na€ ıve knees, and between na€ ıve and sham-operated joints (data not shown).
EAA LEVELS IN THE KNEE JOINT DIALYSATES
IMMUNOHISTOCHEMISTRY OF EAATs
The immunolocalization of GLAST and GLT-1 protein expression in cartilage specimens from na€ ıve and ACLT groups were examined. As shown in Fig. 3 , GLAST and GLT-1 were located in chondrocytes of the superficial and transitional zones of na€ ıve and ACLT knees. Figure 3 (A and B) shows the staining of GLAST and GLT-1 expression in na€ ıve knees, while Fig. 3(C and D) shows the staining of GLAST and GLT-1 expression in the ACLT knees. From the four individual observations, we found that no staining was observed in the negative control [ Fig. 3(E and F) ]. Both na€ ıve and ACLT chondrocytes were positively stained with antibodies against GLAST and GLT-1.
EFFECTS OF ACLT ON THE GLAST AND GLT-1 PROTEIN EXPRESSIONS IN ARTICULAR CARTILAGE OF RABBIT KNEE JOINTS
As shown in Fig. 4(A) , the expression of GLAST and GLT-1 proteins in knee cartilage homogenates (50 mg) was analyzed by western blot of na€ ıve (right and left knees), sham and ACLT knees at week 30 after surgery. The GLAST antibody exhibited a band at w55 kDa (open arrow) and the GLT-1 exhibited a band at w54 kDa (closed arrow). Figure 4 (B and C) shows that the quantification of GLAST and GLT-1 protein expression. The GLAST protein Data are expressed as mean AE SD (mM) of six rabbits. Na€ ıve/L: left knee of na€ ıve rats. expression significantly increased in the cartilage of the ACLT and the sham-operated knees when compared with that in the na€ ıve (both right and left) knees (P < 0.05). Moreover, the GLAST protein expression was significantly higher in the ACLT knees than in the sham-operated knee [ Fig. 4(B) ]. As observed in Fig. 4(C) , GLT-1 expression was only significantly upregulated in the cartilage of the ACLT knees when compared with that in the sham-operated and na€ ıve (both right and left) knees. No difference in the GLAST and GLT-1 protein expressions was observed between the right and left knees of the na€ ıve rabbits. In the present study, EAAC1 protein expression was not observed in the cartilage of any of the knees.
Time after ACL transection (week)
Discussions
The present study confirmed that OA developed 30 weeks following ACLT in rabbits, and a concomitant increase in the glutamate and aspartate concentrations released was observed in the ACLT knees but not in the sham-operated knees. Both na€ ıve and ACLT chondrocytes were positively stained with antibodies against GLAST and Fig. 3 . The distribution of GLAST and GLT-1 protein immunoreactivity in the cartilage of control and ACLT knees. Positive immunoreactivity of GLAST and GLT-1 is indicated by red-brown color. The distribution of anti-GLAST (A) and anti-GLT-1 (B) immunoreactivity of control cartilage; (C) and (D) were ACLT knees stained with antibodies against GLAST and GLT-1, respectively. GLAST positive (arrows) and GLT-1 positive (asterisks) chondrocytes are indicated, including enlarged views of the respective surface zones as insets. The knee joint sections incubated without primary antibody for GLAST (E) or GLT-1 (F) showed no specific staining in the control group. Scale bar ¼ 100 mm.
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Y.-H. Jean et al.: Excitatory amino acids and excitatory amino acid transporters in OA knees GLT-1. More importantly, we observed changes in the EAAT expression in the articular cartilage of the ACLT knees. As compared to the sham-operated and na€ ıve knees, the GLAST and GLT-1 protein expression increased significantly in the articular cartilage of the ACLT knees. To our knowledge, this paper is the first study to directly demonstrate the functional expression of specific EAATs in articular cartilage in relation to the pathogenesis of OA following ACLT of the knees in an animal model. It is well-known that knee instability following a complete ACL tear often induces OA and is accompanied by degradation of the articular cartilage matrix 22 . Consistent with our previous study 13, 17 , OA developed in the rabbits 30 weeks following ACLT in the present study. Synovial inflammation was observed to play an important role in OA progression 2, 3 . The mild-to-moderate inflammatory changes observed in the synovium of the ACLT knees in our study (Table II) were compatible with those observed in previous studies 13, 17, 24 . Previous studies have demonstrated a drastic increase in endogenous glutamate levels (6.25 vs 326 mM) in the synovial fluid obtained from the knees of rheumatoid arthritis (RA) patients 11 , whereas the elevation of glutamate in the synovial fluid was shown to be relevant to the edema and the thermal hyperalgesia in experimental arthritis models 12, 25 . In our present study, the increase in the knee joint width indicated an increase in inflammation with time ( Fig. 1) , and a corresponding increase in the amount of synovial fluid and the concentrations of glutamate and aspartate in the joint dialysates of ACLT knees (Fig. 2) .
Glutamate has been detected in the network of nerve fibers transversing the bone marrow as well as in osteoblasts, where it may be released due to exocytosis 26, 27 . OA-associated pain may arise due to glutamate release from the axons innervating the inflamed region 28 . Flood et al. demonstrated that MK-801 (a non-competitive antagonist of N-methyl-D-aspartate (NMDA) receptors) in RA fibroblast-like synoviocytes induced an increase in matrix metalloproteinase-2 release, whereas non-NMDA ionotropic glutamate receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBOX) inhibited interleukin-6 production; this suggested that glutamate receptor antagonist may influence the RA pathology 29 . Moreover, glutamate receptor antagonists inhibit the proliferation of synovial fibroblasts, suggesting that these antagonists exert a disease-modifying effect on synovial proliferation occurring in RA 30 . In the present study, from week 10 to week 30 after ACLT, increased levels of EAA glutamate and aspartate were observed in the ACLT knee dialysates as compared to those in the sham-operated knee dialysates; this is consistent with our previous study, where early OA development occurred 20 weeks after the ACLT with a concomitant increase in the glutamate and aspartate concentrations in the ACLT knees but not in the sham-operated knees of Wistar rats 13 . These biochemical changes with regard to the EAAs elevation in the dialysates of ACLT knees are contribute to the pathogenesis of OA.
EAATs are known to be responsible for maintaining the homeostasis of the extracellular glutamate concentration; they protect neurons against harmful overstimulation of glutamatergic receptors 31 . Glutamate cytotoxicity is only evident at a high concentration of 10 mM 32 . Genever et al. have previously demonstrated that osteoblasts express GLAST and rapidly accumulate [ 3 H]-glutamate; this provides a possible molecular mechanism for intracellular glutamate accumulation 32 . In our present study, by immunohistochemistical analysis, we found an expression of EAAT isoforms (GLAST and GLT-1) in the chondrocytes of na€ ıve and ACLT cartilage (Fig. 3) . Cultural rat costal chondrocytes were demonstrated to express the glial EAAT GLT-1 33 . To our knowledge, this is the first report of the EAAT protein expression in chondrocytes of na€ ıve and ACLT-induced OA knee cartilage. Our results confirm EAAT expression in chondrocytes. The molecular weights of GLAST and GLT-1 proteins in the CNS were different from those reported in the previous studies; GLAST and GLT-1 immunoreactive bands were detected at 66e70 kDa and 65e70 kDa, respectively, in the neuronal tissue 34, 35 . In the present study, we found that GLAST protein expression significantly increased in the cartilage of the ACLT and sham-operated knees when compared with that in the na€ ıve knees [ Fig. 4(B) ]; the immunoreactive bands of GLAST and GLT-1 were found at w55 kDa and w54 kDa, respectively. Several studies have demonstrated that the molecular weights of GLAST and GLT-1 range from 65 to 70 kDa and 54 to 55 kDa, which correspond to their glycosylated and non-glycosylated forms, respectively 36e39 . Danbolt et al. 37 and Raunser et al. 38 also found a 73 kDa band corresponding to glycosylated GLT-1 and a 55 kDa band corresponding to non-glycosylated GLT-1. Moreover, Conradt et al. 39 also revealed a 65 kDa band corresponding to the glycosylated GLAST and a 56 kDa band for the non-glycosylated GLAST. Both the glycosylation and non-glycosylation of GLAST and GLT-1 did not affect the transport activities 38, 39 . Another possibility of the different molecular weights of EAATs (GLAST and GLT-1) is splice variant. A splice variant of GLAST, namely, GLAST-1a, lacking of exon-3 is expressed in the bone and brain, and its non-glycosylated form has a molecular weights of 54 kDa 40 . Moreover, the exon-9 skipping form of GLAST-1b expresses predominantly in the plasma membrane of apparently abnormal neurons 41, 42 . It suggested that the equivalent exon-9 skipping form of GLAST (GLAST-1b) is a negative effector of function. The exon-9 skipping form of GLT-1 was cloned from human tissues 43e45 and was initially described selectively present in the brain of patients with motor neuron disease of amyotrophic lateral sclerosis, and this splice variant was a causal factor for the pathogenesis of this disease 43 . In our present study, from the result of western blot analysis, it was suggested that both GLAST and GLT-1 proteins expressed in cartilage were not glycosylated.
It is interesting that an increase in GLAST expression was observed in sham-operated knees as compared to na€ ıve knees in our present study; the reason for this feature is yet unclear and requires further investigation. Among the EAAT subtypes, both GLAST and GLT-1 mRNA and proteins have been demonstrated in bone, while the EAAC1 immunoreactivity is absent 15, 40, 46 . However, by the immunohistochemical analysis, EAAC1 protein expression was found in the synovial tissue 47 . In contrast, our present study failed to demonstrate the protein expression of EAAC1 in the knees of all examined rabbits. Collectively, our findings suggest the possibility of a compensatory mechanism of glutamatergic signaling pathways for this increase in EAAT isoform expression and EAA release in the articular cartilage of OA knees. However, the roles of GLAST and GLT-1 in this regard remain unclear. Our present results do not exclude the contribution of other biological substances to the development of OA in ACLT knees.
In conclusion, our results show that OA of the knee is observed in rabbits at 30 weeks after ACLT. An associated increase observed in the glutamate and aspartate levels in the dialysates of the ACLT knees may be involved in the process of OA development. Furthermore, an increase in GLAST and GLT-1 expressions in the ACLT knee cartilage was also demonstrated in immunohistochemistry and western blot data. Understanding the role of glutamate and the regulation of its uptake in animal models of ACLT-induced OA will be helpful for elucidating the mechanisms underlying the pathogenesis of OA and for developing new therapeutic strategies.
